Measurement and Analysis of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Patients with Autoimmune Diseases treated with Mycophenolic Acid

Update Il y a 4 ans
Reference: EUCTR2005-002233-12

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess if a switch from MMF to myfortic® results in improved GI- and/or health-related quality of life outcomes, and to determine the proportion of patients with who are experiencing any GI complaints under MMF-based immunosuppressive treatment.


Inclusion criteria

  • patients with autoimmune diseases treated with MPA

Links